FAQ

Metastatic Pancreatic Adenocarcinoma

An adenocarcinoma that arises from the exocrine pancreatic tissue and has metastasized to other anatomic sites.

Topic mentions per year

Topic mentions per year

2001-2018
051020012018

Related topics

Related topics

14 relations
Abdominal PainDiabetes MellitusEpithelial CellsEpithelium
(More)

Related mentions per year

Related mentions per year

1936-2019
19401960198020002020
Metastatic Pancreatic Adenocarcinoma
Diabetes Mellitus
cancer cell
Abdominal Pain
Pancreas
Gastrointestinal system

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma.
Intravenous liposomal irinotecan injection (Onivyde®) is approved for use in combination with 5-fluorouracil and leucovorin (5-FU… (More)
Is this relevant?
2016
2016
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma.
Pelareorep causes oncolysis in tumor cells with activated Ras. We hypothesized that pelareorep would have efficacy and… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2016
2016
Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma.
OBJECTIVES Development of targeted therapies for pancreatic cancer could be enhanced by a reliable method for noninvasive tumor… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2016
Review
2016
Management of Metastatic Pancreatic Adenocarcinoma.
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal and clinically challenging malignancies to treat, with an… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2016
2016
Metastatic Pancreatic Adenocarcinoma After Total Pancreatectomy Islet Autotransplantation for Chronic Pancreatitis.
Total pancreatectomy with islet autotransplantation (TPIAT) is being used increasingly as a definitive treatment for chronic… (More)
Is this relevant?
2016
2016
Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma
PURPOSE This study focused on implementation of a prognostic scoring index based on clinico-laboratory parameters measured… (More)
  • table 1
  • figure 1
  • table 2
  • table 2
  • table 3
Is this relevant?
Review
2015
Review
2015
Therapeutic Approaches for Metastatic Pancreatic Adenocarcinoma.
Since the US Food and Drug Administration's approval of gemcitabine in 1996, numerous randomized trials have investigated… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2015
2015
Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study.
PURPOSE In Europe, pancreatic cancer (PC) accounts for approximately 2.6% of all new cancer cases and is the fourth leading cause… (More)
  • table I
  • table II
  • figure 1
  • table III
  • figure 2
Is this relevant?
Review
2014
Review
2014
Treatment of metastatic pancreatic adenocarcinoma: a review.
Gemcitabine monotherapy has been the standard of care for patients with metastatic pancreatic cancer for several decades. Despite… (More)
  • table 2
Is this relevant?
Review
2001
Review
2001
Mouse Models of Metastatic Pancreatic Adenocarcinoma.
Pancreatic adenocarcinoma is a deadly disease. Its etiology is unknown, and metastatic disease kills themajority of patients who… (More)
Is this relevant?